1. Home /
  2. Science


For DOCS, the Writing Is on the Wall

Doximity has not finished its decline, according to the charts.

Here's Where DexCom Could Rally

Let's look at the charts and indicators.

United Therapeutics May Need to Take a Breather From the Rally

Let's look at the charts of the biotech.

Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?

Let's check the charts on this biotechnology stock and see if it still has a prayer.

We Have a New AbbVie Price Target After Our Previous One Was Reached

Here's our fresh take on the shares.

Is This Pullback in Knowles Corp a Buying Opportunity?

Patient investors could go long KN at current levels.

Beaten-Down Biogen Could Finally Be Reaching an 'Interesting' Level

The shares have been cut in half over the last six months.

'A' Is for Buying: Agilent Is Resuming Its Uptrend

Here's how traders can play the stock.

Intuitive Surgical Is Rallying Ahead of Earnings

Traders could go long ISRG at current levels.

Medtronic Needs to Rebase Before Being Attractive Again

Stand aside and let things "shake out".